BBVA USA Bancshares’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$362K Sell
5,321
-44
-0.8% -$3.46K 0.02% 448
2020
Q4
$374K Buy
5,365
+235
+5% +$14.6K 0.02% 432
2020
Q3
$263K Buy
5,130
+1,647
+47% +$90.5K 0.02% 463
2020
Q2
$204K Buy
+3,483
New +$193K 0.01% 493
2020
Q1
Sell
-2,848
Closed -$211K 561
2019
Q4
$211K Buy
+2,848
New +$178K 0.01% 500

Other funds holding HQY

BBVA USA Bancshares's HQY Position: Q1 2021 in Review

BBVA USA Bancshares reduced its HealthEquity (HQY) stake by 0.82% in Q1 2021, selling an estimated $3.46K and leaving 5,321 shares worth $362K. The position accounts for 0.02% of the portfolio, ranked #448.

BBVA USA Bancshares first reported a position in HQY in Q4 2019 and has held it in 5 quarters since. The position peaked at $374K in Q4 2020. 285 funds tracked by Wall St. Rank hold HQY as of Q1 2021.

  • BBVA USA Bancshares held 5,321 shares of HealthEquity worth $362K as of Q1 2021.
  • BBVA USA Bancshares sold 44 HealthEquity shares in Q1 2021, an estimated $3.46K.
  • HealthEquity made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #448 holding.
  • BBVA USA Bancshares first reported a position in HealthEquity in Q4 2019 and has held it in 5 quarters since.
  • BBVA USA Bancshares's HealthEquity position peaked at $374K in Q4 2020.
  • 285 funds tracked by Wall St. Rank held HealthEquity as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.